What is the main business of Wenk Labtec Gmbh?

The main business activity of Wenk Labtec Gmbh focuses on wholesale of pharmaceutical goods.

When was the business founded?

The business was registered in the Polish National Court Register (KRS) on June 12, 2015.

Where is the headquarters located?

The headquarters is located at: ul. Kokoszki 50, 62-200 Gniezno.

What is the legal form?

The legal form of this entity is a branch of a foreign entrepreneur.

What period do the latest financial data cover?

The latest available financial statement covers the period from January 1, 2024 to December 31, 2024.

Wenk Labtec GmbhBranch (foreign co.)

Wholesale of pharmaceutical goods

KRS: NIP: REGON:

Overview

Status

Suspended

Registry date

2015-06-12

Registered address

ul. Kokoszki 50, 62-200 Gniezno, Poland

Financials

Only balance sheet data (assets and liabilities) is available. The income statement (P&L) is not available in the source filing for this period.

Revenue history

Filing timeliness

No financial statement for 2025 – the filing deadline has passed. 2 of 6 financial statements were filed late (the longest delay 289 days for 2022).

2025not filed
202420/03/2026
202328/06/2024
202229/04/2024
202122/06/2022
202024/06/2021

Filed on timeDelayFiling deadline

The statements for 2018 report only zeros (no activity).

Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.

Industry

Authorized Representatives

Gunter Wenk – President of the Management Board

Manner of representation

If one member of the management board has been appointed, that member represents the company independently. If several members of the management board have been appointed, the company is represented by two members of the management board jointly or one member of the management board jointly with a commercial proxy.

Beneficial owners

Person	Rights

Debt

No entries in the National Debtors Register (KRZ).

Public aid

Grant date	Purpose	Gross amount	Granting body
Jun 20, 2020	Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts	$272$272	Prezes Zakładu Ubezpieczeń Społecznych
May 30, 2020	Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts	$280$280	Prezes Zakładu Ubezpieczeń Społecznych

Competitors

Name	Revenue	Website
MedivetS.A.	$154,918,799.92	medivet.pl
Dermaticsp. z o.o.	$33,423,317.64	dermatic.pl
EMS - Euromed Medical Solutionsp. z o.o.	$14,713,557.54	euromed.net.pl
MedaseptS.A.	$8,612,031.18	medasept.pl
PHS Hospitalsp. z o.o. + limited partnership	$1,933,301.24	phs.med.pl
Meditechsp. z o.o.	$934,565.46	meditech.pl
PNN Pharmaceuticals sp. z o.o.sp. k.	$267,897.16	pnn.com.pl
Aptekssp. z o.o.	$13,537.42	apteks.com
Cattani Polskasp. z o.o.	–	cattani.com.pl
DKR Medicalsp. z o.o.	–	dkrmedical.pl

Change history

Date	Event
2025-03-01	Business suspended
2025-02-24	Business resumed
2021-07-07	Business suspended
2019-02-21	Address change (Ul. Prądnicka 46, 31-202, Kraków → Ul. Kokoszki 50, 62-200, Gniezno)
2015-06-12	Entered in the register

FAQ

Last updated: 2026-07-17